PSTX News and Press, Poseida Therapeutics Inc. From 04/18/24

Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting PR Newswire Company to deliver three oral and three poster presentations highlighting its portfolio of non-viral genetic medicines Present...

Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus PR Newswire Fully non-viral approach to genetic m...

2024-04-16 10:00:22 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Shor...

2024-04-15 17:21:24 ET Gainers: Macatawa Bank Corporation ( MCBC ) +38% . Biomea Fusion ( BMEA ) +5% . The RealReal ( REAL ) +4% . Cartesian Therapeutics ( RNAC ) +3% . Construction Partners ( ROAD ) +3% . Losers: Poseida...

2024-04-08 17:16:31 ET More on Poseida Therapeutics Poseida: April 2024 Data Could Shed Light On Differentiated CAR-T Advancement Poseida spikes after FDA orphan status for CAR-T therapy Read the full article on Seeking Alpha For further details see: Pose...

Poseida Therapeutics Presents New Phase 1 Data at AACR 2024 Supporting Potential of P-BCMA-ALLO1 Allogeneic CAR-T Therapy to Benefit Broad Range of Patients with Multiple Myeloma PR Newswire Promising early data suggest patients with relapsed/refractory multiple myeloma...

2024-03-26 16:42:37 ET Gainers: nCino  ( NCNO ) +14% . Biomea Fusion ( BMEA ) +7% . Poseida Therapeutics ( PSTX ) +5% . Office Properties Income  ( OPI ) +5% . Canopy Growth Corporation ( CGC ) +4% . Losers: Bow...

2024-03-26 02:58:06 ET More on Poseida Therapeutics Poseida: April 2024 Data Could Shed Light On Differentiated CAR-T Advancement Poseida spikes after FDA orphan status for CAR-T therapy Seeking Alpha’s Quant Rating on Poseida Therapeutics Historical e...

Poseida Therapeutics Appoints Syed Rizvi, M.D., as Chief Medical Officer PR Newswire SAN DIEGO , March 25, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients...

Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference PR Newswire SAN DIEGO , March 19, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatme...